IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Records Rise in First-Quarter Profits

3:30 AM MDT | May 6, 2009 | Deepti Ramesh

Cambrex (East Rutherford, NJ) has recorded a 12% increase in first-quarter net profits, to $4.7 million, compared with the year-ago period. Sales however decreased by nearly 3%, to $60 million. Sales were unfavorably impacted by exchange rates reflecting a stronger U.S. dollar, Cambrex says. Excluding the currency impact, sales increased by 8.7% and this increase is mainly due to higher volumes of two active pharmaceutical ingredients (API) manufactured under long term supply agreements, higher volumes of controlled substances and slightly higher custom...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa